Streetbeat News

Products Services

FLGC

Flora Growth Corp. has launched Element, a new glass and brass bubbler under its premium lifestyle brand, Vessel. This innovative product is expected to enhance Flora's product lineup.

Portfolio Pulse from

November 21, 2024 | 1:45 pm

ALGN

Align Technology has received a CE mark for its Invisalign Palatal Expander System, which is expected to positively impact its stock (ALGN).

Portfolio Pulse from

November 21, 2024 | 1:45 pm

GEHC

The FDA has cleared the XENOVIEW® 3T Chest Coil for use in GE HealthCare MRI systems, enhancing accessibility for institutions using these systems.

Portfolio Pulse from

November 21, 2024 | 1:45 pm

XBIO

Xenetic Biosciences, Inc. presented positive preclinical data on the co-administration of DNase I with CAR T cells, showing potential in treating melanoma lung metastasis. This data supports the use of DNase I to enhance CAR T cell therapy efficacy.

Portfolio Pulse from

November 21, 2024 | 1:45 pm

GTVH

Golden Triangle Ventures, Inc. (OTC PINK: GTVH) will host an exclusive Spaces call on December 11, 2024, to provide a comprehensive update on Destino Ranch.

Portfolio Pulse from

November 21, 2024 | 1:45 pm

DYAI

Dyadic International has received a $3 million grant from the Bill & Melinda Gates Foundation to develop cost-effective monoclonal antibodies for RSV and malaria using its C1 platform technology. This funding aims to support the creation of affordable therapeutics.

Portfolio Pulse from

November 21, 2024 | 1:45 pm

VGT

The article discusses the potential impact of Artificial General Intelligence (AGI) on the market and recommends a Vanguard ETF as a strategic investment to capitalize on this trend.

Portfolio Pulse from

November 21, 2024 | 1:45 pm

SGPYY

AssetMark has integrated TIFIN Sage's AI-driven technology into its wealth management platform to provide personalized solutions for financial advisors.

Portfolio Pulse from

November 21, 2024 | 1:45 pm

GTLL

NANO Nuclear Energy has appointed John G. Vonglis, former CFO of the U.S. Department of Energy, as Executive Director of Global Government Affairs. Vonglis will manage key government relationships as the company develops and licenses advanced microreactors and other nuclear technologies.

Portfolio Pulse from

November 21, 2024 | 1:45 pm

ATOS

Atossa Therapeutics is set to present a poster on (Z)-Endoxifen at the AACR Special Conference, highlighting its anti-cancer activity in ERα+ breast cancer.

Portfolio Pulse from

November 21, 2024 | 1:45 pm